| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 611 |
| 1 | METHOTREXATE SODIUM | 433 |
| 2 | METHOTREXATE | 416 |
| 3 | TACROLIMUS | 396 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 379 |
| 5 | TACROLIMUS OINTMENT 0.1% | 379 |
| 6 | MYCOPHENOLATE MOFETIL | 348 |
| 7 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 348 |
| 8 | INFLIXIMAB | 342 |
| 9 | ADALIMUMAB | 187 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ITRACONAZOLE | 88 | 0.0074 |
| 1 | METHSCOPOLAMINE BROMIDE | 1 | 0.0069 |
| 2 | PURIXAN | 5 | 0.0064 |
| 3 | VANCOMYCIN HYDROCHLORIDE | 52 | 0.0062 |
| 4 | HYDROCORTISONE 2.5% | 1 | 0.0062 |
| 5 | AMPHOTERICIN B | 60 | 0.0047 |
| 6 | DEMECLOCYCLINE | 1 | 0.0044 |
| 7 | MYCOPHENILIC ACID | 93 | 0.0044 |
| 8 | FINGOLIMOD HYDROCHLORIDE | 19 | 0.0037 |
| 9 | BELATACEPT | 16 | 0.0034 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 817 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 499 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 415 |
| 3 | Purine Antimetabolite [EPC] | 128 |
| 4 | Azole Antifungal [EPC] | 118 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 93 |
| 6 | Polyene Antifungal [EPC] | 70 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 68 |
| 8 | Lipid-based Polyene Antifungal [EPC] | 65 |
| 9 | Glycopeptide Antibacterial [EPC] | 52 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lipid-based Polyene Antifungal [EPC] | 65 | 0.0051 |
| 1 | Antimetabolite Immunosuppressant [EPC] | 93 | 0.0044 |
| 2 | Selective T Cell Costimulation Blocker [EPC] | 16 | 0.0034 |
| 3 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 3 | 0.0024 |
| 4 | Macrolide Antibacterial [EPC] | 2 | 0.0020 |
| 5 | Polyene Antifungal [EPC] | 70 | 0.0017 |
| 6 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 18 | 0.0013 |
| 7 | Purine Antimetabolite [EPC] | 128 | 0.0013 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 415 | 0.0009 |
| 9 | CD52-directed Cytolytic Antibody [EPC] | 18 | 0.0009 |